COMMUNIQUÉS West-GlobeNewswire

Anthogyr rejoint le Groupe Straumann
12/03/2019
Straumann Group augmente sa participation dans le fabricant français d'implants Anthogyr de 30% à 100%. Anthogyr, société privée, fournit au Groupe Straumann une gamme supplémentaire de solutions implantaires de haute [...]
Nexstim Plc is planning a rights issue
12/03/2019
Company Announcement, Helsinki, 12 March 2019 at 2.00 pm (EET) Nexstim Plc is planning a Rights Issue Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and marketing pioneering [...]
Forty Seven Inc. to Present at Oppenheimer 29th Annual Healthcare Conference
12/03/2019
MENLO PARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV), a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Join Achieve TMS East to Celebrate the Grand Opening of its Andover Location
12/03/2019
ANDOVER, Mass., March 12, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East, Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and obsessive-compulsive [...]
Anthogyr joins the Straumann Group
12/03/2019
Straumann Group increases stake in French implant manufacturer Anthogyr from 30% to full ownership Privately-held Anthogyr provides Straumann Group with an additional range of attractively-priced high-quality implant [...]
IBEX Reports Plans to Close Iowa Production Facility
12/03/2019
MONTREAL, March 12, 2019 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture: IBT) today reported that it plans to close its Iowa production facility as of July 31, 2019. The Iowa [...]
Krystal Biotech Reports 2018 Financial Results and Business Progress
12/03/2019
Topline-data from Phase 1/2 clinical trial of KB103 (bercolagene telserpavec) for treatment dystrophic epidermolysis bullosa (DEB) to be announced in 1H 2019 Ancoris, a cGMP facility for clinical and commercial [...]
Bio-Research Products Reports Plans to Close North Liberty Production Facility
12/03/2019
NORTH LIBERTY, Iowa, March 12, 2019 (GLOBE NEWSWIRE) -- Bio-Research Products Inc. today reported that it plans to close its North Liberty production facility as of July 31, 2019. Bio-Research Products (“BRP”) produces [...]
CymaBay Therapeutics to Present at Upcoming Investor Conferences in March
12/03/2019
NEWARK, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]
Synthorx to Present at the Chinese Society for Clinical Oncology Conference on Immunotherapy
12/03/2019
SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics [...]
Pluristem Therapeutics Announces Completion of 2nd Cohort and DSMB Approval to Enroll Final Cohort in Phase I Hematological Study of PLX-R18
12/03/2019
Findings from first two cohorts show primary safety endpoint met and early signals of efficacy HAIFA, Israel, March 12, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) , a leading [...]
Sport Endurance Completes Transition to Better Choice Company and Begins Trading Under the Symbol ‘BTTR’
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Sport Endurance, Inc. (OTC QB: SENZ) announced today that it has received final FINRA approval to complete its reincorporation to Better Choice Company, Inc. (the “Company [...]
Cannabis Stocks That Could See Significant Growth in Retail
12/03/2019
VANCOUVER, British Columbia, March 12, 2019 (GLOBE NEWSWIRE) -- Cannabis sales have been soaring since legalization in Canada but there's a lot more to come as the industry continues to change. With more retailers [...]
TG Therapeutics, Inc. Announces Data Presentation at the Upcoming American Academy of Neurology 71st Annual Meeting
12/03/2019
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that data from the Phase 2 multicenter trial evaluating ublituximab (TG-1101), the Company’s novel glycoengineered anti- [...]
CFN Media Interviews New High Hampton CEO Gary Latham
12/03/2019
SEATTLE, March 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Major Players in the Bottled Water Space
12/03/2019
VANCOUVER, British Columbia, March 12, 2019 (GLOBE NEWSWIRE) -- With U.S. bottled water sales volumes reaching roughly 13.7 billion gallons in 2017 according to Statista , the United States presents the world’s largest [...]
AzurRx BioPharma Announces Poster Presentation at the Americas Hepato-Pancreato-Biliary Association 2019 Annual Meeting
12/03/2019
Poster to Focus on Phase II Trial of MS1819-SD in Chronic Pancreatitis NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in the [...]
Nephros Reports 2018 Fourth Quarter and Full Year Financial Results and Provides Corporate Update
12/03/2019
Annual Product Revenues Up 54% SOUTH ORANGE, N.J., March 12, 2019 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both [...]
Merus sera présente à la 39e conférence annuelle sur les soins de la santé de Cowen & Co.
12/03/2019
UTRECHT, Pays-Bas, 12 mars 2019 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », « nous » « notre » ou la « Société »), entreprise d'immuno-oncologie de stade clinique qui développe des traitements innovants à [...]

Pages